Overall, 18 articles were included in the meta-analysis to evaluate the prognosis and the clinical significance of survivin in ovarian cancer, whereas 10 [18,21,22,23,24,25,26,27,28,29] reported data for HR with 95% CI (directly and indirectly) (Figure 1) [30]. This evidence concerns the gene BIRC5 and ovarian cancer.